- Home
- RNA vs UMBF Comparison
RNA vs UMBF Comparison
Compare RNA & UMBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNA
- UMBF
- Stock Information
- Founded
- RNA 2012
- UMBF 1913
- Country
- RNA United States
- UMBF United States
- Employees
- RNA N/A
- UMBF N/A
- Industry
- RNA Biotechnology: Pharmaceutical Preparations
- UMBF Major Banks
- Sector
- RNA Health Care
- UMBF Finance
- Exchange
- RNA Nasdaq
- UMBF Nasdaq
- Market Cap
- RNA 4.0B
- UMBF 8.7B
- IPO Year
- RNA 2020
- UMBF N/A
- Fundamental
- Price
- RNA $40.06
- UMBF $120.54
- Analyst Decision
- RNA Strong Buy
- UMBF Buy
- Analyst Count
- RNA 16
- UMBF 9
- Target Price
- RNA $69.81
- UMBF $135.00
- AVG Volume (30 Days)
- RNA 3.7M
- UMBF 474.5K
- Earning Date
- RNA 11-06-2025
- UMBF 10-28-2025
- Dividend Yield
- RNA N/A
- UMBF 1.33%
- EPS Growth
- RNA N/A
- UMBF 12.71
- EPS
- RNA N/A
- UMBF 8.74
- Revenue
- RNA $10,729,000.00
- UMBF $1,949,350,000.00
- Revenue This Year
- RNA N/A
- UMBF $67.80
- Revenue Next Year
- RNA $109.60
- UMBF $7.53
- P/E Ratio
- RNA N/A
- UMBF $13.79
- Revenue Growth
- RNA 1.23
- UMBF 31.18
- 52 Week Low
- RNA $21.51
- UMBF $82.00
- 52 Week High
- RNA $56.00
- UMBF $129.94
- Technical
- Relative Strength Index (RSI)
- RNA 41.60
- UMBF 54.54
- Support Level
- RNA $39.83
- UMBF $117.74
- Resistance Level
- RNA $46.23
- UMBF $126.14
- Average True Range (ATR)
- RNA 2.92
- UMBF 2.96
- MACD
- RNA -1.24
- UMBF -0.78
- Stochastic Oscillator
- RNA 27.77
- UMBF 41.30
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.
About UMBF UMB Financial Corporation
UMB Financial Corp, or UMBF, is a financial services holding company offering a suite of banking services and asset servicing to its customers in the United States and around the world. Its client base includes commercial, institutional, and personal customers. Along with its subsidiaries, the company operates in the following business segments: Commercial Banking, Institutional Banking, and Personal Banking. A majority of its revenue is generated from the Commercial Banking segment, which serves the commercial banking and treasury management needs of small to middle-market businesses through various products and services such as commercial loans, commercial real estate financing, commercial credit cards, letters of credit, loan syndication services, consultative services, and others.